Boston Scientific to Add New European Institute for Therapy Advancement Campus to Global Medical Education Network

Natick, Massachusetts and Paris (ots/PRNewswire) -

- New Second-Generation Training Center in Brussels to Help
Medical Professionals Advance Standard of Patient Care

Boston Scientific Corporation (NYSE: BSX) today announced plans
for the construction of a new state-of-the art medical training
facility in Brussels, Belgium designed to help health care
professionals advance the standard of patient care. The Company
expects the new addition to be completed in early 2007.

"From our work at the Institute for Therapy Advancement over the
past five years, we have learned which type of training is important
to health care professionals," said Professor Jean Marco of the
Institute Pasteur in Toulouse. "This experience is a guide to
building a second generation Institute that better addresses the
specific needs of medical professionals at all levels."

The new facility will be able to host thousands of health care
professionals annually and will offer medical education and skills
training on the latest developments in the medical device field.
Founded in 2000 by Guidant, the Institute for Therapy Advancement is
a leader in medical education programs that address the real-world
practical needs of health care professionals and is now part of a
Boston Scientific global medical education network with campuses in
Tokyo, Japan, Brussels, Belgium and St. Paul, Minnesota in the United
States. Boston Scientific acquired Guidant on April 21.

"This new Institute for Therapy Advancement facility is a
reflection of our commitment to helping physicians put into practice
the latest developments and guidelines," said Jeff Goodman, Senior
Vice President and President of International of Boston Scientific.
"We understand that time is a scarce resource for clinicians today so
the effectiveness and efficiency of continued medical education has
become increasingly important."

Programs at the Institute for Therapy Advancement are designed and
taught by independent physician experts. As a result, the majority of
programs hosted by the Institute are CME accredited. More than 15,000
health care professionals have participated in the Institute's
programs to date.

Boston Scientific is a worldwide developer, manufacturer and
marketer of medical devices whose products are used in a broad range
of interventional medical specialties. For more information, please
visit: www.bostonscientific.com.

This press release contains forward-looking statements. The
Company wishes to caution the reader of this press release that
actual results may differ from those discussed in the forward-looking
statements and may be adversely affected by, among other things,
risks associated with the regulatory approval process, reimbursement
policies, commercialization of new technologies, education and
training of health care professionals, litigation, the Company's
overall business strategy and other factors described in the
Company's filings with the Securities and Exchange Commission.

NATICK, Massachusetts and PARIS, May 17 /PRNewswire/ --

ots Originaltext: Boston Scientific Corporation
Im Internet recherchierbar: http://www.presseportal.de

Contact:
For further information, please contact: Geraldine Varoqui, Boston
Scientific PR Manager International, Tel: +49-2102-489-461,
varoquig@bsci.com; Maren Koban, BSC press office, Tel:
+44-(0)20-7973-4497, mkoban@hillandknowlton.com